Alkogol'naya bolezn' pecheni: immunologicheskie mekhanizmy patogeneza - novyy vzglyad na tselesoobraznost' primeneniya S-adenozil-L-metoinina


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article considers the mechanisms of development of alcoholic liver disease (ALD); morphological and clinical characteristics of the different forms of the disease are presented. The significance of immune disorders in the pathogenesis of ALD, including the neoantigen formation and production of autoantibodies, is discussed. The data on the significance of cytokine disorders in the pathogenesis of ALD and promising approaches to the treatment are represented. Difficulties in the treatment of special groups of ALD patients, which include persons with liver cirrhosis and attacks of acute alcoholic hepatitis, are emphasized. The use of S-adenosyl-L-methionine (Heptral), a preparation with a broad spectrum of hepatoprotective properties, including anti-cytokine activity, can give effectual help in their treatment.

Full Text

Restricted Access

References

  1. Nephew TM, Williams GD, Stinson FS, et al. Apparent per Capita Alcohol Consumption: National, State and Regional Trends, 20002004 (NIAAA Surveillance Report, № 5), Washington, D.C., CSR. Inc.
  2. Kerr WC, Fillmore KM, Marvy P. Beverage-specific alcohol consumption and cirrhosis mortality in a group of English-speaking beer-drinking countries. Addiction 2000;95(3):339-46.
  3. Drinking in the United States: Main Findings from the 1992 to 2004 National Longitudinal Alcohol Epidemiologic Survey (NLAES) - NIH Publication, № 99-3519, 2005.
  4. Cook RT. Alcochol abuse, alcocholism and damage to the immune system - a review. Alcochol Clin Exp Res 1999;22:1927-42.
  5. Diaz LT, Montero A, Gonzales-Gross M. Influence of alcochol consumption on immunological status: a review. Eur J Clin Nutr 2002;56(3):S50-54.
  6. Messingham KA, Faunce DV, Kovacs EJ. Alcochol, injury and cellular immunity. Alcochol 2002;28:137-49.
  7. Zetterman RK, Sorrell MF. Immunologic aspects of alcocholic liver disease. Gastroenterology 2001;81:616-24.
  8. Gluud C, Christoffersen P, Eriksen J. Influence of ethanol on development of hyperplastic nodules in alcocholic men with micronodulap cirrhosis. Gastroenterology 1999;93:256-60.
  9. Tuma DJ, Sorrell MF. Alcocholic Liver Disease: Pathology and Pathogtntsis, 2nd ed., London: Edvard Arnold, 1999:89-99.
  10. Sorrell MF, Tuma DJ. Hypotesis: alcocholic liver injury and the covalent binding of acetaldehyde. Alcochol Clin Exp Res 1998;9:306-10.
  11. Israel Y, Orrego H, Niemela J. Immune responc-es to alcochol metabolites: pathogenic and diagnostic implications. Semin Liver Dis 1998;
  12. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Ann Rev Cell Biol 1998;9:317-43.
  13. McClain CJ, Hill DB. Cytokines and alcocholic liver disease. Sem Liver Dis 1998;13:170-82.
  14. Trautwein C, Rakemann T, Niehof M. Acute-phase responce factor, increased binding and target gene transcription during liver regeneration. Gastroenterology 1999;110:1854-62.
  15. Yin M, Wheeler MD, Kono H. Essential role of tumor necrosis factor alpha in alcochol induced liver injury. Gastroenterology 2000; 117:942-52.
  16. Herbert T, Diehl AM. Cytokines in Alcocholic and Nonalcocholic Steatohepatitis. N Eng J Med 2000;343:1467-76.
  17. Feldman M, Friedmann LS, Shleisenger MY. Gastrointestinal and Liver Disease (Pathophysiology, Diagnosis, Management). Saunders, Philadelphia, 7th ed., 2002.
  18. Song Z, Zhou S, Cools F, at al. S-adenoslmethionin and proinflammatory cytokines profiles among the patients with acute alcoholic liver injury. Liv Dis 2010;245:320-32.
  19. Mato JM, Camara J, Fernandez de Paz J, at al. S-adenosil-l-methionine in patients with alcoholic liver disaese: a multicenter, randomized, double-blinde trials. J.Hepatology 1999;30:1081-89.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies